The global Neurologic Disorder Treatment Drug market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Neurologic Disorder Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Neurologic Disorder Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurologic Disorder Treatment Drug. This report contains market size and forecasts of Neurologic Disorder Treatment Drug in global, including the following market information:
Global Neurologic Disorder Treatment Drug market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Neurologic Disorder Treatment Drug companies in 2024 (%)
Total Market by Segment:
Global Neurologic Disorder Treatment Drug market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Neurologic Disorder Treatment Drug market segment percentages, by Type, 2024 (%)
Anticholinergic
Antiepileptic
Antipsychotic
Hypnotic and Sedative
Analgesics
Antihypertensive
Anticoagulants
Others
Global Neurologic Disorder Treatment Drug market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Neurologic Disorder Treatment Drug market segment percentages, by Application, 2024 (%)
Epilepsy
Alzheimer�s Disease
Parkinson's Disease
Multiple Sclerosis
Cerebrovascular Disease
Others
Global Neurologic Disorder Treatment Drug market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Neurologic Disorder Treatment Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurologic Disorder Treatment Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Neurologic Disorder Treatment Drug revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Acadia Pharmaceuticals
Acorda Therapeutics Biotechnology
Bayer
Biogen
CSK
Eisai
F. Hoffmann La Roche
H Lundbeck
Johnson and Johnson
Merck
Novartis
Otsuka Pharmaceutical
Pfizer
Sanofi
Takeda Pharmaceutical
Teva Pharmaceutical Industries
UCB
USWM
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neurologic Disorder Treatment Drug, market overview.
Chapter 2: Global Neurologic Disorder Treatment Drug market size in revenue.
Chapter 3: Detailed analysis of Neurologic Disorder Treatment Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neurologic Disorder Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Neurologic Disorder Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Neurologic Disorder Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurologic Disorder Treatment Drug Overall Market Size
2.1 Global Neurologic Disorder Treatment Drug Market Size: 2024 VS 2032
2.2 Global Neurologic Disorder Treatment Drug Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neurologic Disorder Treatment Drug Players in Global Market
3.2 Top Global Neurologic Disorder Treatment Drug Companies Ranked by Revenue
3.3 Global Neurologic Disorder Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Neurologic Disorder Treatment Drug Companies in Global Market, by Revenue in 2024
3.5 Global Companies Neurologic Disorder Treatment Drug Product Type
3.6 Tier 1, Tier 2, and Tier 3 Neurologic Disorder Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Neurologic Disorder Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Neurologic Disorder Treatment Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Neurologic Disorder Treatment Drug Market Size Markets, 2024 & 2032
4.1.2 Anticholinergic
4.1.3 Antiepileptic
4.1.4 Antipsychotic
4.1.5 Hypnotic and Sedative
4.1.6 Analgesics
4.1.7 Antihypertensive
4.1.8 Anticoagulants
4.1.9 Others
4.2 Segmentation by Type - Global Neurologic Disorder Treatment Drug Revenue & Forecasts
4.2.1 Segmentation by Type - Global Neurologic Disorder Treatment Drug Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Neurologic Disorder Treatment Drug Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Neurologic Disorder Treatment Drug Market Size, 2024 & 2032
5.1.2 Epilepsy
5.1.3 Alzheimer�s Disease
5.1.4 Parkinson's Disease
5.1.5 Multiple Sclerosis
5.1.6 Cerebrovascular Disease
5.1.7 Others
5.2 Segmentation by Application - Global Neurologic Disorder Treatment Drug Revenue & Forecasts
5.2.1 Segmentation by Application - Global Neurologic Disorder Treatment Drug Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Neurologic Disorder Treatment Drug Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Neurologic Disorder Treatment Drug Market Size, 2024 & 2032
6.2 By Region - Global Neurologic Disorder Treatment Drug Revenue & Forecasts
6.2.1 By Region - Global Neurologic Disorder Treatment Drug Revenue, 2020-2025
6.2.2 By Region - Global Neurologic Disorder Treatment Drug Revenue, 2026-2032
6.2.3 By Region - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Neurologic Disorder Treatment Drug Revenue, 2020-2032
6.3.2 United States Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.3.3 Canada Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.3.4 Mexico Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Neurologic Disorder Treatment Drug Revenue, 2020-2032
6.4.2 Germany Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.4.3 France Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.4.4 U.K. Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.4.5 Italy Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.4.6 Russia Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.4.7 Nordic Countries Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.4.8 Benelux Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Neurologic Disorder Treatment Drug Revenue, 2020-2032
6.5.2 China Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.5.3 Japan Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.5.4 South Korea Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.5.5 Southeast Asia Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.5.6 India Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Neurologic Disorder Treatment Drug Revenue, 2020-2032
6.6.2 Brazil Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.6.3 Argentina Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue, 2020-2032
6.7.2 Turkey Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.7.3 Israel Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.7.4 Saudi Arabia Neurologic Disorder Treatment Drug Market Size, 2020-2032
6.7.5 UAE Neurologic Disorder Treatment Drug Market Size, 2020-2032
7 Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Neurologic Disorder Treatment Drug Major Product Offerings
7.1.4 AbbVie Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.1.5 AbbVie Key News & Latest Developments
7.2 Acadia Pharmaceuticals
7.2.1 Acadia Pharmaceuticals Corporate Summary
7.2.2 Acadia Pharmaceuticals Business Overview
7.2.3 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Major Product Offerings
7.2.4 Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.2.5 Acadia Pharmaceuticals Key News & Latest Developments
7.3 Acorda Therapeutics Biotechnology
7.3.1 Acorda Therapeutics Biotechnology Corporate Summary
7.3.2 Acorda Therapeutics Biotechnology Business Overview
7.3.3 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Major Product Offerings
7.3.4 Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.3.5 Acorda Therapeutics Biotechnology Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Neurologic Disorder Treatment Drug Major Product Offerings
7.4.4 Bayer Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.4.5 Bayer Key News & Latest Developments
7.5 Biogen
7.5.1 Biogen Corporate Summary
7.5.2 Biogen Business Overview
7.5.3 Biogen Neurologic Disorder Treatment Drug Major Product Offerings
7.5.4 Biogen Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.5.5 Biogen Key News & Latest Developments
7.6 CSK
7.6.1 CSK Corporate Summary
7.6.2 CSK Business Overview
7.6.3 CSK Neurologic Disorder Treatment Drug Major Product Offerings
7.6.4 CSK Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.6.5 CSK Key News & Latest Developments
7.7 Eisai
7.7.1 Eisai Corporate Summary
7.7.2 Eisai Business Overview
7.7.3 Eisai Neurologic Disorder Treatment Drug Major Product Offerings
7.7.4 Eisai Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.7.5 Eisai Key News & Latest Developments
7.8 F. Hoffmann La Roche
7.8.1 F. Hoffmann La Roche Corporate Summary
7.8.2 F. Hoffmann La Roche Business Overview
7.8.3 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Major Product Offerings
7.8.4 F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.8.5 F. Hoffmann La Roche Key News & Latest Developments
7.9 H Lundbeck
7.9.1 H Lundbeck Corporate Summary
7.9.2 H Lundbeck Business Overview
7.9.3 H Lundbeck Neurologic Disorder Treatment Drug Major Product Offerings
7.9.4 H Lundbeck Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.9.5 H Lundbeck Key News & Latest Developments
7.10 Johnson and Johnson
7.10.1 Johnson and Johnson Corporate Summary
7.10.2 Johnson and Johnson Business Overview
7.10.3 Johnson and Johnson Neurologic Disorder Treatment Drug Major Product Offerings
7.10.4 Johnson and Johnson Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.10.5 Johnson and Johnson Key News & Latest Developments
7.11 Merck
7.11.1 Merck Corporate Summary
7.11.2 Merck Business Overview
7.11.3 Merck Neurologic Disorder Treatment Drug Major Product Offerings
7.11.4 Merck Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.11.5 Merck Key News & Latest Developments
7.12 Novartis
7.12.1 Novartis Corporate Summary
7.12.2 Novartis Business Overview
7.12.3 Novartis Neurologic Disorder Treatment Drug Major Product Offerings
7.12.4 Novartis Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.12.5 Novartis Key News & Latest Developments
7.13 Otsuka Pharmaceutical
7.13.1 Otsuka Pharmaceutical Corporate Summary
7.13.2 Otsuka Pharmaceutical Business Overview
7.13.3 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Major Product Offerings
7.13.4 Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.13.5 Otsuka Pharmaceutical Key News & Latest Developments
7.14 Pfizer
7.14.1 Pfizer Corporate Summary
7.14.2 Pfizer Business Overview
7.14.3 Pfizer Neurologic Disorder Treatment Drug Major Product Offerings
7.14.4 Pfizer Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.14.5 Pfizer Key News & Latest Developments
7.15 Sanofi
7.15.1 Sanofi Corporate Summary
7.15.2 Sanofi Business Overview
7.15.3 Sanofi Neurologic Disorder Treatment Drug Major Product Offerings
7.15.4 Sanofi Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.15.5 Sanofi Key News & Latest Developments
7.16 Takeda Pharmaceutical
7.16.1 Takeda Pharmaceutical Corporate Summary
7.16.2 Takeda Pharmaceutical Business Overview
7.16.3 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Major Product Offerings
7.16.4 Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.16.5 Takeda Pharmaceutical Key News & Latest Developments
7.17 Teva Pharmaceutical Industries
7.17.1 Teva Pharmaceutical Industries Corporate Summary
7.17.2 Teva Pharmaceutical Industries Business Overview
7.17.3 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Major Product Offerings
7.17.4 Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.17.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.18 UCB
7.18.1 UCB Corporate Summary
7.18.2 UCB Business Overview
7.18.3 UCB Neurologic Disorder Treatment Drug Major Product Offerings
7.18.4 UCB Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.18.5 UCB Key News & Latest Developments
7.19 USWM
7.19.1 USWM Corporate Summary
7.19.2 USWM Business Overview
7.19.3 USWM Neurologic Disorder Treatment Drug Major Product Offerings
7.19.4 USWM Neurologic Disorder Treatment Drug Revenue in Global Market (2020-2025)
7.19.5 USWM Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Neurologic Disorder Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Neurologic Disorder Treatment Drug Market Drivers in Global Market
Table 3. Neurologic Disorder Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Neurologic Disorder Treatment Drug in Global Market
Table 5. Top Neurologic Disorder Treatment Drug Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Neurologic Disorder Treatment Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Neurologic Disorder Treatment Drug Revenue Share by Companies, 2020-2025
Table 8. Global Companies Neurologic Disorder Treatment Drug Product Type
Table 9. List of Global Tier 1 Neurologic Disorder Treatment Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurologic Disorder Treatment Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Neurologic Disorder Treatment Drug Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Neurologic Disorder Treatment Drug Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2026-2032
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Neurologic Disorder Treatment Drug Product Offerings
Table 32. AbbVie Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 33. AbbVie Key News & Latest Developments
Table 34. Acadia Pharmaceuticals Corporate Summary
Table 35. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Product Offerings
Table 36. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 37. Acadia Pharmaceuticals Key News & Latest Developments
Table 38. Acorda Therapeutics Biotechnology Corporate Summary
Table 39. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Product Offerings
Table 40. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 41. Acorda Therapeutics Biotechnology Key News & Latest Developments
Table 42. Bayer Corporate Summary
Table 43. Bayer Neurologic Disorder Treatment Drug Product Offerings
Table 44. Bayer Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 45. Bayer Key News & Latest Developments
Table 46. Biogen Corporate Summary
Table 47. Biogen Neurologic Disorder Treatment Drug Product Offerings
Table 48. Biogen Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 49. Biogen Key News & Latest Developments
Table 50. CSK Corporate Summary
Table 51. CSK Neurologic Disorder Treatment Drug Product Offerings
Table 52. CSK Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 53. CSK Key News & Latest Developments
Table 54. Eisai Corporate Summary
Table 55. Eisai Neurologic Disorder Treatment Drug Product Offerings
Table 56. Eisai Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 57. Eisai Key News & Latest Developments
Table 58. F. Hoffmann La Roche Corporate Summary
Table 59. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Product Offerings
Table 60. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 61. F. Hoffmann La Roche Key News & Latest Developments
Table 62. H Lundbeck Corporate Summary
Table 63. H Lundbeck Neurologic Disorder Treatment Drug Product Offerings
Table 64. H Lundbeck Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 65. H Lundbeck Key News & Latest Developments
Table 66. Johnson and Johnson Corporate Summary
Table 67. Johnson and Johnson Neurologic Disorder Treatment Drug Product Offerings
Table 68. Johnson and Johnson Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 69. Johnson and Johnson Key News & Latest Developments
Table 70. Merck Corporate Summary
Table 71. Merck Neurologic Disorder Treatment Drug Product Offerings
Table 72. Merck Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 73. Merck Key News & Latest Developments
Table 74. Novartis Corporate Summary
Table 75. Novartis Neurologic Disorder Treatment Drug Product Offerings
Table 76. Novartis Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 77. Novartis Key News & Latest Developments
Table 78. Otsuka Pharmaceutical Corporate Summary
Table 79. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Product Offerings
Table 80. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 81. Otsuka Pharmaceutical Key News & Latest Developments
Table 82. Pfizer Corporate Summary
Table 83. Pfizer Neurologic Disorder Treatment Drug Product Offerings
Table 84. Pfizer Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 85. Pfizer Key News & Latest Developments
Table 86. Sanofi Corporate Summary
Table 87. Sanofi Neurologic Disorder Treatment Drug Product Offerings
Table 88. Sanofi Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 89. Sanofi Key News & Latest Developments
Table 90. Takeda Pharmaceutical Corporate Summary
Table 91. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Product Offerings
Table 92. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 93. Takeda Pharmaceutical Key News & Latest Developments
Table 94. Teva Pharmaceutical Industries Corporate Summary
Table 95. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Product Offerings
Table 96. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 97. Teva Pharmaceutical Industries Key News & Latest Developments
Table 98. UCB Corporate Summary
Table 99. UCB Neurologic Disorder Treatment Drug Product Offerings
Table 100. UCB Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 101. UCB Key News & Latest Developments
Table 102. USWM Corporate Summary
Table 103. USWM Neurologic Disorder Treatment Drug Product Offerings
Table 104. USWM Neurologic Disorder Treatment Drug Revenue (US$, Mn) & (2020-2025)
Table 105. USWM Key News & Latest Developments
List of Figures
Figure 1. Neurologic Disorder Treatment Drug Product Picture
Figure 2. Neurologic Disorder Treatment Drug Segment by Type in 2024
Figure 3. Neurologic Disorder Treatment Drug Segment by Application in 2024
Figure 4. Global Neurologic Disorder Treatment Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Neurologic Disorder Treatment Drug Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Neurologic Disorder Treatment Drug Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Neurologic Disorder Treatment Drug Revenue in 2024
Figure 9. Segmentation by Type � Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
Figure 13. By Region - Global Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
Figure 14. By Country - North America Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
Figure 15. United States Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
Figure 19. Germany Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 20. France Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
Figure 27. China Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 31. India Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
Figure 33. Brazil Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Neurologic Disorder Treatment Drug Revenue Market Share, 2020-2032
Figure 36. Turkey Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Neurologic Disorder Treatment Drug Revenue, (US$, Mn), 2020-2032
Figure 40. AbbVie Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Acadia Pharmaceuticals Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Acorda Therapeutics Biotechnology Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Bayer Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Biogen Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. CSK Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Eisai Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. F. Hoffmann La Roche Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. H Lundbeck Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Johnson and Johnson Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Merck Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Novartis Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Otsuka Pharmaceutical Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Pfizer Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Sanofi Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Takeda Pharmaceutical Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. Teva Pharmaceutical Industries Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. UCB Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 58. USWM Neurologic Disorder Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
